Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.
People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
In a year where insurers have expanded coverage for multiple medical treatments, federal employees will see their Federal ...
For 22 years, Jason Mazzola’s life was defined by a genetic condition that can cause autism and intellectual disability. Then ...
University of Iowa Health Care is looking for volunteers to take part in a national study of a drug that shows promise in the treatment of Alzheimer’s disease. Dr. Del Miller, the UI’s principal ...
Hosted on MSN5d
12 Memory Problems that Look Like Alzheimer’s—But Aren’tMemory lapses aren't always caused by Alzheimer's. Depression, infections or even vitamin deficiencies may be the reason.
The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.
Understanding the puzzling link between depression and problems with memory may lead to more powerful treatments for the mood ...
Dr. Elizabeth Gromisch discusses her study, which showed the feasibility of a telehealth intervention for teaching ...
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss ...
In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback